Jay Moon Lee

Title(s)Associate Professor, Surgery
SchoolMedicine
vCardDownload vCard
    Other Positions
    Title(s)Associate Professor, Medicine


    Collapse Research 
    Collapse Research Activities and Funding
    Gene Modified Dendritic Cell Therapy in Lung Cancer
    NIH K23CA131577Aug 1, 2009 - Jul 31, 2014
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Accelerated Hypofractionated Chemoradiation Followed by Stereotactic Ablative Radiotherapy Boost for Locally Advanced, Unresectable Non-Small Cell Lung Cancer: A Nonrandomized Controlled Trial. JAMA Oncol. 2024 Jan 11. Wu TC, Luterstein E, Neilsen BK, Goldman JW, Garon EB, Lee JM, Felix C, Cao M, Tenn SE, Low DA, Kupelian PA, Steinberg ML, Lee P. PMID: 38206614; PMCID: PMC10784998.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Unresectable Stage III NSCLC Should Not be Treated With Neoadjuvant Therapy and Re-Evaluated for Resection. J Thorac Oncol. 2023 09; 18(9):1129-1133. Moghanaki D, Lisberg A, Oh S, Lee JM. PMID: 37599046.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. Neoadjuvant Targeted Therapy in Resectable NSCLC: Current and Future Perspectives. J Thorac Oncol. 2023 11; 18(11):1458-1477. Lee JM, McNamee CJ, Toloza E, Negrao MV, Lin J, Shum E, Cummings AL, Kris MG, Sepesi B, Bara I, Kurtsikidze N, Schulze K, Ngiam C, Chaft JE. PMID: 37451404.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    4. Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2023 09 01; 117(1):118-122. Wu TC, Stube A, Felix C, Oseguera D, Romero T, Goldman J, Garon EB, Lee JM, Glaspy J, Lisberg AE, Rusthoven CG, Camidge DR, Siva S, Solomon B, Lee A, Tenn SE, Shaverdian N, Steinberg ML, Raldow AC, Lee P. PMID: 37023987.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    5. Effect of Bilateral Cardiac Sympathetic Denervation on Burden of Premature Ventricular Contractions. Circ Arrhythm Electrophysiol. 2023 04; 16(4):e011546. Sridharan A, Tang A, Sorg JM, Hoftman NN, Lee JM, Yanagawa J, Vaseghi M. PMID: 36916281; PMCID: PMC10132769.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Economic Burden of Recurrence Among Resected Medicare Patients With Early Stage NSCLC. JTO Clin Res Rep. 2023 Apr; 4(4):100487. Lee JM, Wang R, Johnson A, Ogale S, Kent M, Lee JS. PMID: 37007869; PMCID: PMC10050774.
      View in: PubMed   Mentions: 2  
    7. Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non-small cell lung cancer in the randomized phase III IMpower010 trial. J Thorac Cardiovasc Surg. 2023 09; 166(3):655-666.e7. Lee JM, Vallières E, Ding B, Johnson A, Bhagwakar J, Rashidi S, Zhu QC, Gitlitz BJ, Weksler B, Costas K, Altorki N. PMID: 36841745.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    8. Real-world adjuvant chemotherapy patterns and outcomes among elderly patients with resected early non-small-cell lung cancer in the USA. Future Oncol. 2023 Jan; 19(1):37-47. Lee JM, Wang R, Johnson A, Ogale S, Kent M, Lee JS. PMID: 36662515.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Overcoming immunosuppression and pro-tumor inflammation in lung cancer with combined IL-1β and PD-1 inhibition. Future Oncol. 2022 Sep; 18(27):3085-3100. Lee JM, Tsuboi M, Kim ES, Mok TS, Garrido P. PMID: 36004638.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    10. Commentary: The search for a chemotherapy-free immunotherapy regimen in resectable non-small cell lung cancer: The unmet need. J Thorac Cardiovasc Surg. 2022 Aug 03. Lee JM. PMID: 35987868.
      View in: PubMed   Mentions:    Fields:    
    11. Neoadjuvant immunotherapy in resectable non-small cell lung cancer at a checkpoint. Transl Lung Cancer Res. 2021 Dec; 10(12):4328-4335. Faltermeier CM, Lee JM. PMID: 35070744; PMCID: PMC8743523.
      View in: PubMed   Mentions:
    12. Technical Feasibility and Safety of Repeated Computed Tomography-Guided Transthoracic Intratumoral Injection of Gene-Modified Cellular Immunotherapy in Metastatic NSCLC. JTO Clin Res Rep. 2021 Nov; 2(11):100242. Shahrouki P, Lee JM, Barclay J, Khan SN, Genshaft S, Abtin F, Dubinett SM, Lisberg A, Sharma S, Garon EB, Suh R. PMID: 34806054; PMCID: PMC8581369.
      View in: PubMed   Mentions:
    13. Important Surgical and Clinical End Points in Neoadjuvant Immunotherapy Trials in Resectable NSCLC. JTO Clin Res Rep. 2021 Oct; 2(10):100221. Lee JM, Kim AW, Marjanski T, Falcoz PE, Tsuboi M, Wu YL, Sun SW, Gitlitz BJ. PMID: 34746882; PMCID: PMC8552106.
      View in: PubMed   Mentions: 11  
    14. Surgical Perspective on Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer. Ann Thorac Surg. 2022 10; 114(4):1505-1515. Lee JM, Tsuboi M, Brunelli A. PMID: 34339672.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    15. Arrhythmic Risk Profile and Outcomes of Patients Undergoing Cardiac Sympathetic Denervation for Recurrent Monomorphic Ventricular Tachycardia After Ablation. J Am Heart Assoc. 2021 01 19; 10(2):e018371. Dusi V, Gornbein J, Do DH, Sorg JM, Khakpour H, Krokhaleva Y, Ajijola OA, Macias C, Bradfield JS, Buch E, Fujimura OA, Boyle NG, Yanagawa J, Lee JM, Shivkumar K, Vaseghi M. PMID: 33441022; PMCID: PMC7955320.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    16. Minimally Invasive Bilateral Stellate Ganglionectomy for Refractory Ventricular Tachycardia. Ann Thorac Surg. 2021 04; 111(4):e295-e296. Elliott IA, DeJesus M, Dobaria V, Vaseghi M, Ajijola OA, Shivkumar K, Hoftman NN, Benharash P, Lee JM, Yanagawa J. PMID: 33419566.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Minimally Invasive Bilateral Stellate Ganglionectomy for Refractory Ventricular Tachycardia. JACC Clin Electrophysiol. 2021 04; 7(4):533-535. Elliott IA, DeJesus M, Dobaria V, Vaseghi M, Ajijola OA, Shivkumar K, Hoftman NN, Benharash P, Lee JM, Yanagawa J. PMID: 33419708.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    18. Recurrent ventricular tachycardia after cardiac sympathetic denervation: Prolonged cycle length with improved hemodynamic tolerance and ablation outcomes. J Cardiovasc Electrophysiol. 2020 09; 31(9):2382-2392. Hayase J, Dusi V, Do D, Ajijola OA, Vaseghi M, Lee JM, Yanagawa J, Hoftman N, Revels S, Buch EF, Khakpour H, Fujimura O, Krokhaleva Y, Macias C, Sorg J, Gima J, Pavez G, Boyle NG, Shivkumar K, Bradfield JS. PMID: 32558054; PMCID: PMC7719072.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    19. Prognostic impact of atrial rhythm and dimension in patients with structural heart disease undergoing cardiac sympathetic denervation for ventricular arrhythmias. Heart Rhythm. 2020 05; 17(5 Pt A):714-720. Dusi V, Sorg JM, Gornbein J, Gima J, Yanagawa J, Lee JM, Vecerek N, Vaseghi M, Bradfield JS, De Ferrari GM, Shivkumar K, Ajijola OA. PMID: 31837474; PMCID: PMC7196021.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    20. VATS lobectomy for early lung cancer: long-term outcomes. Ann Transl Med. 2019 Sep; 7(Suppl 6):S235. Toste PA, Lee JM. PMID: 31656814; PMCID: PMC6789362.
      View in: PubMed   Mentions: 1  
    21. The Immune Contexture Associates with the Genomic Landscape in Lung Adenomatous Premalignancy. Cancer Res. 2019 Oct 01; 79(19):5022-5033. Krysan K, Tran LM, Grimes BS, Fishbein GA, Seki A, Gardner BK, Walser TC, Salehi-Rad R, Yanagawa J, Lee JM, Sharma S, Aberle DR, Spira AE, Elashoff DA, Wallace WD, Fishbein MC, Dubinett SM. PMID: 31142513; PMCID: PMC6774823.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    22. Predictors of Outcomes After Thoracic Surgery in Orthotopic Liver Transplant Recipients With Pleural Disease. Semin Thorac Cardiovasc Surg. 2019; 31(3):604-611. Shirali AS, Grotts J, Elashoff D, Barjaktarevic I, Melamed KH, Van Hassel J, Cameron RB, Lee JM, Yanagawa J. PMID: 30731193.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    23. The Evolving Epidemiology and Management of Spontaneous Pneumothorax. JAMA. 2018 10 09; 320(14):1441-1443. Savitsky E, Oh SS, Lee JM. PMID: 30304415.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    24. Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by 68Ga-PSMA-11 PET/CT. Clin Genitourin Cancer. 2019 02; 17(1):e53-e55. Polverari G, Ceci F, Allen-Auerbach M, Gupta P, Fishbein MC, Reiter RE, Lee JM, Hope TA, Carroll RM, Czernin J, Calais J. PMID: 30293922.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    25. A Prospective Phase 2 Study Evaluating Safety and Efficacy of Combining Stereotactic Body Radiation Therapy With Heat-based Ablation for Centrally Located Lung Tumors. Int J Radiat Oncol Biol Phys. 2018 07 01; 101(3):564-573. Sandler KA, Abtin F, Suh R, Cook RR, Felix C, Lee JM, Garon EB, Wu J, Luterstein EM, Agazaryan N, Tenn SE, Lee C, Steinberg ML, Lee P. PMID: 29893274.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    26. Anti-angiogenic therapy in nonsquamous non-small cell lung cancer (NSCLC) with tyrosine kinase inhibition (TKI) that targets the VEGF receptor (VEGFR): perspective on phase III clinical trials. J Thorac Dis. 2018 Feb; 10(2):617-620. Revels SL, Lee JM. PMID: 29607123; PMCID: PMC5864582.
      View in: PubMed   Mentions: 5  
    27. Atrioesophageal Fistula After Atrial Fibrillation Ablation: A single center series. J Atr Fibrillation. 2017 Oct-Nov; 10(3):1654. Khakpour H, Shemin RJ, Lee JM, Buch E, Boyle NG, Shivkumar K, Bradfield JS. PMID: 29250244; PMCID: PMC5725752.
      View in: PubMed   Mentions: 7  
    28. Inflammation, oxidative stress, and glial cell activation characterize stellate ganglia from humans with electrical storm. JCI Insight. 2017 09 21; 2(18). Ajijola OA, Hoover DB, Simerly TM, Brown TC, Yanagawa J, Biniwale RM, Lee JM, Sadeghi A, Khanlou N, Ardell JL, Shivkumar K. PMID: 28931760; PMCID: PMC5621921.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    29. Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration. Clin Cancer Res. 2017 Aug 15; 23(16):4556-4568. Lee JM, Lee MH, Garon E, Goldman JW, Salehi-Rad R, Baratelli FE, Schaue D, Wang G, Rosen F, Yanagawa J, Walser TC, Lin Y, Park SJ, Adams S, Marincola FM, Tumeh PC, Abtin F, Suh R, Reckamp KL, Lee G, Wallace WD, Lee S, Zeng G, Elashoff DA, Sharma S, Dubinett SM. PMID: 28468947; PMCID: PMC5599263.
      View in: PubMed   Mentions: 94     Fields:    Translation:HumansCellsCTClinical Trials
    30. Limited resection versus lobectomy in early-stage non-small cell lung cancer. J Thorac Dis. 2016 Nov; 8(11):E1511-E1513. Toste PA, Lee JM. PMID: 28066646; PMCID: PMC5179473.
      View in: PubMed   Mentions: 3  
    31. Surgical Treatment of Lung Cancer. Cancer Treat Res. 2016; 170:77-104. Onugha OI, Lee JM. PMID: 27535390.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Primary salivary duct carcinoma of the lung, mucin-rich variant. Hum Pathol. 2016 Jan; 47(1):150-6. Fishbein GA, Grimes BS, Xian RR, Lee JM, Barjaktarevic I, Xu H. PMID: 26527521.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma. Pract Radiat Oncol. 2015 Nov-Dec; 5(6):366-73. Kishan AU, Cameron RB, Wang PC, Alexander S, Qi SX, Low DA, Kupelian PA, Steinberg ML, Lee JM, Selch MT, Lee P. PMID: 26432677.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    34. GITR agonist enhances vaccination responses in lung cancer. Oncoimmunology. 2015 Apr; 4(4):e992237. Zhu LX, Davoodi M, Srivastava MK, Kachroo P, Lee JM, St John M, Harris-White M, Huang M, Strieter RM, Dubinett S, Sharma S. PMID: 26137407; PMCID: PMC4485739.
      View in: PubMed   Mentions: 8     Fields:    
    35. Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway. J Cancer Sci Ther. 2014 Nov; 6(11):468-477. Lee MH, Kachroo P, Pagano PC, Yanagawa J, Wang G, Walser TC, Krysan K, Sharma S, John MS, Dubinett SM, Lee JM. PMID: 26523208; PMCID: PMC4624255.
      View in: PubMed   Mentions: 7  
    36. Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomas. J Thorac Cardiovasc Surg. 2015 Jan; 149(1):85-92. Lin AY, Kotova S, Yanagawa J, Elbuluk O, Wang G, Kar N, Elashoff D, Grogan T, Cameron RB, Singh A, Chmielowski B, Federman N, Nelson SD, Lee P, Eilber FC, Lee JM. PMID: 25312228.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    37. Incidental mediastinal dose does not explain low mediastinal node recurrence rates in patients with early-stage NSCLC treated with stereotactic body radiotherapy. Clin Lung Cancer. 2014 Jul; 15(4):287-93. Rwigema JC, Chen AM, Wang PC, Lee JM, Garon E, Lee P. PMID: 24594401.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    38. IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer. J Exp Clin Cancer Res. 2013 Nov 25; 32:97. Kachroo P, Lee MH, Zhang L, Baratelli F, Lee G, Srivastava MK, Wang G, Walser TC, Krysan K, Sharma S, Dubinett SM, Lee JM. PMID: 24274066; PMCID: PMC3906956.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    39. Safety and efficacy of stereotactic body radiation therapy in the treatment of pulmonary metastases from high grade sarcoma. Sarcoma. 2013; 2013:360214. Mehta N, Selch M, Wang PC, Federman N, Lee JM, Eilber FC, Chmielowski B, Agazaryan N, Steinberg M, Lee P. PMID: 24198717; PMCID: PMC3807836.
      View in: PubMed   Mentions: 12  
    40. Elevated neutrophil gelatinase-associated lipocalin contributes to erlotinib resistance in non-small cell lung cancer. Am J Transl Res. 2013; 5(5):481-96. Krysan K, Cui X, Gardner BK, Reckamp KL, Wang X, Hong L, Walser TC, Rodriguez NL, Pagano PC, Garon EB, Brothers JF, Elashoff D, Lee JM, Spira AE, Sharma S, Fishbein MC, Dubinett SM. PMID: 23977408; PMCID: PMC3745436.
      View in: PubMed   Mentions: 13  
    41. CCL21 Chemokine Therapy for Lung Cancer. Int Trends Immun. 2013 Jan; 1(1):10-15. Sharma S, Zhu L, Srivastava MK, Harris-White M, Huang M, Lee JM, Rosen F, Lee G, Wang G, Kickhoefer V, Rome LH, Baratelli F, St John M, Reckamp K, Chul-Yang S, Hillinger S, Strieter R, Dubinett S. PMID: 25264541; PMCID: PMC4175527.
      View in: PubMed   Mentions: 9  
    42. Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer. Immunotargets Ther. 2012 Oct 01; 2012(1):7-12. Srivastava MK, Zhu L, Harris-White M, Huang M, St John M, Lee JM, Salgia R, Cameron RB, Strieter R, Dubinett S, Sharma S. PMID: 24791250; PMCID: PMC4004632.
      View in: PubMed   Mentions: 14  
    43. Myeloid suppressor cell depletion augments antitumor activity in lung cancer. PLoS One. 2012; 7(7):e40677. Srivastava MK, Zhu L, Harris-White M, Kar UK, Kar U, Huang M, Johnson MF, Lee JM, Elashoff D, Strieter R, Dubinett S, Sharma S. PMID: 22815789; PMCID: PMC3398024.
      View in: PubMed   Mentions: 119     Fields:    Translation:AnimalsCellsPHPublic Health
    44. Development of transcriptomic biomarker signature in human saliva to detect lung cancer. Cell Mol Life Sci. 2012 Oct; 69(19):3341-3350. Zhang L, Xiao H, Zhou H, Santiago S, Lee JM, Garon EB, Yang J, Brinkmann O, Yan X, Akin D, Chia D, Elashoff D, Park NH, Wong DTW. PMID: 22689099; PMCID: PMC4121486.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCells
    45. Myeloid suppressor cells and immune modulation in lung cancer. Immunotherapy. 2012 Mar; 4(3):291-304. Srivastava MK, Andersson Å, Zhu L, Harris-White M, Lee JM, Dubinett S, Sharma S. PMID: 22401635; PMCID: PMC3324285.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansAnimalsCells
    46. Single-institution, multidisciplinary experience with surgical resection of primary chest wall sarcomas. J Thorac Oncol. 2012 Mar; 7(3):552-8. Kachroo P, Pak PS, Sandha HS, Lee C, Elashoff D, Nelson SD, Chmielowski B, Selch MT, Cameron RB, Holmes EC, Eilber FC, Lee JM. PMID: 22307013.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    47. Chest wall sarcomas are accurately diagnosed by image-guided core needle biopsy. J Thorac Oncol. 2012 Jan; 7(1):151-6. Kachroo P, Pak PS, Sandha HS, Nelson SD, Seeger LL, Cameron RB, Eilber FC, Lee JM. PMID: 21900839.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    48. Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry. Mol Cell Proteomics. 2012 Feb; 11(2):M111.012112. Xiao H, Zhang L, Zhou H, Lee JM, Garon EB, Wong DT. PMID: 22096114; PMCID: PMC3277759.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCells
    49. Surgical management of endobronchial solitary fibrous tumors. Ann Thorac Surg. 2010 Aug; 90(2):659-61. Pak PS, Yanagawa J, Abtin F, Wallace WD, Holmes EC, Lee JM. PMID: 20667378; PMCID: PMC3158992.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    50. Chemokines: can effector cells be redirected to the site of the tumor? Cancer J. 2010 Jul-Aug; 16(4):325-35. Dubinett SM, Lee JM, Sharma S, Mulé JJ. PMID: 20693843; PMCID: PMC3076643.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimals
    51. Resection of thyroid cancer metastases to the sternum. J Thorac Oncol. 2009 Aug; 4(8):1022-5. Yanagawa J, Abtin F, Lai CK, Yeh M, Britten CD, Martinez D, Crisera CA, Holmes EC, Lee JM. PMID: 19633476.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    52. Smoking and lung cancer: the role of inflammation. Proc Am Thorac Soc. 2008 Dec 01; 5(8):811-5. Walser T, Cui X, Yanagawa J, Lee JM, Heinrich E, Lee G, Sharma S, Dubinett SM. PMID: 19017734; PMCID: PMC4080902.
      View in: PubMed   Mentions: 115     Fields:    Translation:Humans
    53. Vitamin D-mediated hypercalcemia and Cushing syndrome as manifestations of malignant pleural mesothelioma. Endocr Pract. 2008 Nov; 14(8):1011-6. Lee JM, Pou K, Sadow PM, Chen H, Hu B, Hewison M, Adams JS, Sugarbaker DJ, Fisher ND. PMID: 19095601.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    54. Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer. J Transl Med. 2008 Jul 22; 6:38. Baratelli F, Takedatsu H, Hazra S, Peebles K, Luo J, Kurimoto PS, Zeng G, Batra RK, Sharma S, Dubinett SM, Lee JM. PMID: 18644162; PMCID: PMC2507704.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    55. Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment. Crit Rev Oncol Hematol. 2008 Jun; 66(3):208-17. Lee JM, Yanagawa J, Peebles KA, Sharma S, Mao JT, Dubinett SM. PMID: 18304833; PMCID: PMC2483429.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansCells
    56. Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistance. J Thorac Oncol. 2008 Feb; 3(2):107-10. Krysan K, Lee JM, Dohadwala M, Gardner BK, Reckamp KL, Garon E, St John M, Sharma S, Dubinett SM. PMID: 18303428.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    57. Inflammation and lung carcinogenesis: applying findings in prevention and treatment. Expert Rev Anticancer Ther. 2007 Oct; 7(10):1405-21. Peebles KA, Lee JM, Mao JT, Hazra S, Reckamp KL, Krysan K, Dohadwala M, Heinrich EL, Walser TC, Cui X, Baratelli FE, Garon E, Sharma S, Dubinett SM. PMID: 17944566.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimals
    58. Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLC. Future Oncol. 2007 Apr; 3(2):149-53. Lee JM, Mao JT, Krysan K, Dubinett SM. PMID: 17381414.
      View in: PubMed   Mentions: 7     Fields:    
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Jay's Networks
    Concepts (246)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (65)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California